浅谈阿奇霉素治疗小儿肺炎的效果

Talking about the Effect of Azithromycin in Treating Children with Pneumonia

目的深入研讨在临床治疗小儿肺炎中施以阿奇霉素的临床应用价值,旨在为后续治疗提供可靠理论依据。方法随机筛选于2017年3月至2018年3月入院接受诊治的820例小儿肺炎患儿,平均分配为X组与Y组,各为410例。X组(n=410)施以阿奇霉素治疗,Y组(n=410)施以红霉素治疗。将两组的施行疗效、不良反应发生情况、临床症状消失时间进行分析与比较。结果 X组的施行疗效明显优于Y组(P<0.05);X组的不良反应少于Y组(P<0.05);相比于Y组,X组的临床症状消失时间得到明显缩短(P<0.05)。结论在临床治疗小儿肺炎中施以阿奇霉素,施行疗效更具有代表性,安全性高,有利于加速患儿早日恢复身体健康,医疗价值高。

Objective To study the clinical application value of azithromycin in the treatment of children with pneumonia in order to provide reliable theoretical basis for follow-up treatment. Methods A total of 820 children with pneumonia who were admitted to the hospital between March 2017 and March 2018 were randomly assigned to an average of X and Y groups, each with 410 patients. X group(n=410) was treated with azithromycin and group Y(n =410) was treated with erythromycin. The efficacy, adverse reactions, and disappearance of clinical symptoms of the two groups were analyzed and compared. Results The efficacy of group X was significantly better than that of group Y(P<0.05). The adverse reactions of group X were less than that of group Y(P<0.05). Compared with group Y, the disappearance time of clinical symptoms in group X was significantly shortened(P< 0.05). Conclusion The application of azithromycin in clinical treatment of pneumonia in children is more representative and safe. It is beneficial to accelerate the recovery of health of children as soon as possible and has high medical value.